Inexpensive drug can prevent cerebral palsy in premature babies
A study from the University of Bristol found that giving women at risk of premature birth a magnesium sulphate (drip) can help prevent their babies from developing cerebral palsy.
The first major review in 2009 showed this treatment was effective, and new research continues to confirm it. Since 2015, the World Health Organization has recommended it for women at risk of giving birth before 32 weeks. However, many places still struggle to put this into practice.
In England, a health programme successfully expanded magnesium sulphate treatment to all NHS maternity units. Between 2018 and 2023, the treatment was given to over 14,000 women, preventing an estimated 385 cases of cerebral palsy.
Even though the treatment is proven to be affordable and life-changing, not all mothers are receiving it. Data from the Vermont Oxford Network, which includes over 1,400 neonatal units worldwide (mainly in the USA), shows about two-thirds of eligible women get the treatment. This number may be lower in poorer areas not well represented in the data.
Learn more about The University of Bristol's magnesium sulphate infusion findings
Categories
- All Categories
- 14.1K Start here and say hello!
- 6.8K Coffee lounge
- 63 Games den
- 1.6K People power
- 89 Community noticeboard
- 21.8K Talk about life
- 5K Everyday life
- 52 Current affairs
- 2.2K Families and carers
- 819 Education and skills
- 1.8K Work
- 432 Money and bills
- 3.3K Housing and independent living
- 880 Transport and travel
- 650 Relationships
- 60 Sex and intimacy
- 1.3K Mental health and wellbeing
- 2.3K Talk about your impairment
- 845 Rare, invisible, and undiagnosed conditions
- 892 Neurological impairments and pain
- 1.9K Cerebral Palsy Network
- 1.1K Autism and neurodiversity
- 35.4K Talk about your benefits
- 5.6K Employment and Support Allowance (ESA)
- 18.4K PIP, DLA, and AA
- 6.4K Universal Credit (UC)
- 5K Benefits and income